HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
Sys. Review
Narrative review examines antioxidant metabolites for autism spectrum disorder in children
Could antioxidant nutrients help children with autism spectrum disorder?
This narrative review evaluates the potential role of antioxidant metabolites from botanical drugs and nutrients, including vitamins E and C…
Antioxidant nutrients like vitamins E and C, plus botanical compounds, may help address oxidative stress linked to autism spectrum disorder …
Frontiers
Apr 19, 2026
Drug Pipeline
Sys. Review
Review of flavonoids shows preclinical neuroprotective potential in Parkinson's disease models
Parkinson's drugs may need a new partner
This narrative review synthesizes preclinical evidence regarding flavonoids including baicalein, quercetin, apigenin, luteolin, and EGCG in …
Plant-based compounds could one day help treat Parkinson's by fixing multiple brain chemicals at once, not just dopamine.
Frontiers
Apr 18, 2026
Diabetes & Endocrinology
RCT
Review of quercetin in metabolic diseases shows promise but lacks clinical validation.
Review suggests quercetin may have multiple beneficial effects on metabolic conditions
This review evaluates quercetin for conditions including diabetes, obesity, and gout. While the medication demonstrates favorable human tole…
A natural compound found in fruits and vegetables shows promise for managing type 2 diabetes, obesity, and fatty liver disease, though human…
Frontiers
Apr 13, 2026
Infectious Disease
Phase II
Dasatinib and Quercetin Show Promise in Improving Gait Speed in HIV-Associated Frailty
Can a New Drug Combination Help Older Adults with HIV Regain Strength?
Phase II trial of dasatinib and quercetin (D+Q) in 82 HIV+ frail/prefrail adults shows potential in improving gait speed. Primary endpoint: …
A new trial tests if two drugs help older adults with HIV regain strength and walk better after years of frailty.
CT.gov
Mar 27, 2026